ProfileGDS5068 / 219862_s_at
TitleRheumatoid arthritic synovium response to tocilizumab
OrganismHomo sapiens


baseline tocilizumab patient 1 patient 2 patient 3 patient 4 patient 5 patient 6 patient 7 patient 8 patient 9 patient 10 patient 11 patient 12 patient 1 patient 2 patient 3 patient 4 patient 5 patient 6 patient 7 patient 8 patient 9 patient 10 patient 11 patient 12 GSM1116933 GSM1116935 GSM1116937 GSM1116939 GSM1116941 GSM1116943 GSM1116945 GSM1116947 GSM1116949 GSM1116951 GSM1116953 GSM1116955 GSM1116934 GSM1116936 GSM1116938 GSM1116940 GSM1116942 GSM1116944 GSM1116946 GSM1116948 GSM1116950 GSM1116952 GSM1116954 GSM1116956 13% 57% 63% 43% 19% 78% 73% 54% 28% 40% 66% 63% 66% 63% 32% 84% 30% 25% 53% 47% 39% 21% 35% 63% sort by agent sort by individual Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1116933Synovial tissue prior to Tocilizumab therapy, repl 1-0.26534613
GSM1116935Synovial tissue prior to Tocilizumab therapy, repl 20.02490957
GSM1116937Synovial tissue prior to Tocilizumab therapy, repl 30.052696263
GSM1116939Synovial tissue prior to Tocilizumab therapy, repl 4-0.011331643
GSM1116941Synovial tissue prior to Tocilizumab therapy, repl 5-0.13412219
GSM1116943Synovial tissue prior to Tocilizumab therapy, repl 60.14580278
GSM1116945Synovial tissue prior to Tocilizumab therapy, repl 70.15328473
GSM1116947Synovial tissue prior to Tocilizumab therapy, repl 8-0.0007154
GSM1116949Synovial tissue prior to Tocilizumab therapy, repl 9-0.10360128
GSM1116951Synovial tissue prior to Tocilizumab therapy, repl 10-0.046967540
GSM1116953Synovial tissue prior to Tocilizumab therapy, repl 110.080614166
GSM1116955Synovial tissue prior to Tocilizumab therapy, repl 120.054477763
GSM1116934Synovial tissue after to Tocilizumab therapy, repl 10.078180366
GSM1116936Synovial tissue after to Tocilizumab therapy, repl 20.082596863
GSM1116938Synovial tissue after to Tocilizumab therapy, repl 3-0.068836232
GSM1116940Synovial tissue after to Tocilizumab therapy, repl 40.34269584
GSM1116942Synovial tissue after to Tocilizumab therapy, repl 5-0.10761830
GSM1116944Synovial tissue after to Tocilizumab therapy, repl 6-0.094632125
GSM1116946Synovial tissue after to Tocilizumab therapy, repl 7-0.00072253
GSM1116948Synovial tissue after to Tocilizumab therapy, repl 8-0.012913747
GSM1116950Synovial tissue after to Tocilizumab therapy, repl 9-0.056703639
GSM1116952Synovial tissue after to Tocilizumab therapy, repl 10-0.14136521
GSM1116954Synovial tissue after to Tocilizumab therapy, repl 11-0.057468435
GSM1116956Synovial tissue after to Tocilizumab therapy, repl 120.049645463